Below is the text of the page https://www.biofarma.ua/imprint stored 2023-07-22 by archive.org.ua. The original page over time could change. View as original html

STADA Arzneimittel AG - Your Partner in Health | STADA

[/] Company Products Stories Sustainability Investors Media Career About STADA Management Our Corporate Culture STADA worldwide Company history Compliance About STADA STADA worldwide Consumer Healthcare Products Specialty Pharmaceuticals Generics Partnerships Quality at STADA Adverse drug reaction report Consumer Healthcare Products Specialty Pharmaceuticals People Health Research Sustainability People Stories Health At a Glance News Stock Bonds Financial Publications Calendar General Meeting Corporate Governance IR Contact STADA Financial Calendar Financial Publications Newsroom Press Releases Press Photos STADA Health Reports Social Media Media Contact Press Releases STADA Health Report 2022 STADA Accelerate Learn more about STADA Experience our culture Discover your Opportunities Get to know us How to find your dream job at STADA Experience our culture Career portal en Deutsch (DE) 123 Company Products Stories Sustainability Investors Media Career English | Deutsch Select your country Back Websites worldwide Australia STADA Pharmaceuticals Australia Pty. Ltd STADA Pharmaceuticals (Asia) Ltd Asia Pacific region Austria STADA Arzneimittel GmbH SCIOTEC Diagnostic Technologies GmbH Azerbaijan Azerbaijan Belarus STADA Belarus Belgium EG nv Bosnia-Herzegovina Hemofarm Banja Luka d.o.o Bulgaria Stada Bulgaria China STADA Pharmaceuticals (Beijing) Ltd STADA Pharmaceuticals (Asia) Ltd Asia Pacific region Croatia STADA d.o.o. Czech Republic STADA PHARMA CZ, s.r.o. Walmark a.s. Denmark STADA NORDIC ApS France EG LABO - Laboratoires EuroGenerics Germany ALIUD PHARMA® GmbH STADA Consumer Health Deutschland GmbH STADAPHARM GmbH Hungary STADA Hungary Ireland Clonmel Healthcare Limited Italy EG S.p.A. Kazakhstan Nizhpharm-Kasachstan TOO DO Lithuania UAB STADA-Nizhpharm-Baltija Montenegro Hemomont d.o.o. Netherlands Centrafarm B.V. Healthypharm B.V. Poland STADA Poland Sp. z o.o. Portugal STADA, LDA Romania STADA M&D, Romania Russia STADA Russia & CIS Saudi Arabia STADA MENA DWC LLC Serbia Hemofarm A.D. Slovakia STADA PHARMA Slovakia s.r.o Slovenia STADA d.o.o. Spain LABORATORIO STADA, SLU Switzerland Spirig HealthCare AG Thailand STADA Pharmaceuticals (Asia) Ltd Asia Pacific region The Phillippines STADA Pharmaceuticals (Asia) Ltd Asia Pacific region United Arab Emirates STADA MENA DWC LLC United Kingdom Natures Aid Ltd Thornton & Ross Ltd. Britannia Pharmaceuticals Ltd Uzbekistan STADA Uzbekistan Vietnam Pymepharco JSC STADA Vietnam STADA Pharmaceuticals (Asia) Ltd Asia Pacific region Back Company About STADA Management Our Corporate Culture STADA worldwide Company history Compliance Back Products Consumer Healthcare Products Specialty Pharmaceuticals Generics Partnerships Quality at STADA Adverse drug reaction report Back Stories People Health Research Sustainability Back Investors At a Glance News Stock Bonds Financial Publications Calendar General Meeting Corporate Governance IR Contact Back Media Newsroom Press Releases Press Photos STADA Health Reports Social Media Media Contact Back Career STADA Accelerate Learn more about STADA Experience our culture Discover your Opportunities Get to know us How to find your dream job at STADA 123 Select your country Australia Austria Azerbaijan Belarus Belgium Bosnia-Herzegovina Bulgaria China Croatia Czech Republic Denmark France Germany Hungary Ireland Italy Kazakhstan Lithuania Montenegro Netherlands Poland Portugal Romania Russia Saudi Arabia Serbia Slovakia Slovenia Spain Switzerland Thailand The Phillippines United Arab Emirates United Kingdom Uzbekistan Vietnam Websites worldwide Select a country to go to the website of the respective STADA sales company. Australia (2) STADA Pharmaceuticals Australia Pty. Ltd STADA Pharmaceuticals (Asia) Ltd Asia Pacific region Austria (2) STADA Arzneimittel GmbH SCIOTEC Diagnostic Technologies GmbH Azerbaijan (1) Azerbaijan Belarus (1) STADA Belarus Belgium (1) EG nv Bosnia-Herzegovina (1) Hemofarm Banja Luka d.o.o Bulgaria (1) Stada Bulgaria China (2) STADA Pharmaceuticals (Beijing) Ltd STADA Pharmaceuticals (Asia) Ltd Asia Pacific region Croatia (1) STADA d.o.o. Czech Republic (2) STADA PHARMA CZ, s.r.o. Walmark a.s. Denmark (1) STADA NORDIC ApS France (1) EG LABO - Laboratoires EuroGenerics Germany (3) ALIUD PHARMA® GmbH STADA Consumer Health Deutschland GmbH STADAPHARM GmbH Hungary (1) STADA Hungary Ireland (1) Clonmel Healthcare Limited Italy (1) EG S.p.A. Kazakhstan (1) Nizhpharm-Kasachstan TOO DO Lithuania (1) UAB STADA-Nizhpharm-Baltija Montenegro (1) Hemomont d.o.o. Netherlands (2) Centrafarm B.V. Healthypharm B.V. Poland (1) STADA Poland Sp. z o.o. Portugal (1) STADA, LDA Romania (1) STADA M&D, Romania Russia (1) STADA Russia & CIS Saudi Arabia (1) STADA MENA DWC LLC Serbia (1) Hemofarm A.D. Slovakia (1) STADA PHARMA Slovakia s.r.o Slovenia (1) STADA d.o.o. Spain (1) LABORATORIO STADA, SLU Switzerland (1) Spirig HealthCare AG Thailand (1) STADA Pharmaceuticals (Asia) Ltd Asia Pacific region The Phillippines (1) STADA Pharmaceuticals (Asia) Ltd Asia Pacific region United Arab Emirates (1) STADA MENA DWC LLC United Kingdom (3) Natures Aid Ltd Thornton & Ross Ltd. Britannia Pharmaceuticals Ltd Uzbekistan (1) STADA Uzbekistan Vietnam (3) Pymepharco JSC STADA Vietnam STADA Pharmaceuticals (Asia) Ltd Asia Pacific region STADA is acquiring additional brands from Sanofi Read more STADA appoints Christos Gallis as Head of Eastern Europe Read more STADA sets standard in Specialty Read more Sustainability Read more STADA’s Culture Drives Performance Go to LinkedIn Explore STADA Sustainability For better and sustainable health, STADA contributes to SDG 9 by constantly working on innovations to its product portfolio. Diversity & Inclusion Our culture thrives on empowering our people to bring forward their unique and diverse experiences. Trusted Partner Central to STADA's commitment to caring for people's health through consumer healthcare products, generics and specialty medicines are close partnerships to improve health globally. Culture Our employees drive STADA’s growth culture. This is energized by the actions of our people every day to bring health to society as One STADA team. Patient Health & Safety STADA promotes access to affordable, effective and high-quality medicines. We are committed to improving the quality of life of patients. Three-pillar Strategy The company focuses on consumer healthcare products, generics and speciality medicines. Your opportunity for success with STADA We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment. Careers at STADA Latest news 01/06/2023 STADA: FDA approves biologics facility to supply key medicine to patients in US Read more 03/04/2023 STADA and Xbrane launch ranibizumab to support patient access in Europe Read more 06/03/2023 STADA sustains strong momentum with double-digit sales and profit growth in 2022 Read more 09/02/2023 EMA Confirms Acceptance of Application for AVT04 Read more 11/01/2023 Adalvo and STADA extend their strategic partnership Read more 02/01/2023 STADA appoints Boris Döbler as Chief Financial Officer Read more Sustainability stories Read more Growth mindset: Our people are our ambassadors Follow us on LinkedIn My winning formula? A unique growth mindset as key strategic pillar to outgrow the industry! By Peter Goldschmidt, CEO of STADA A special bond between a unique group of great leaders! By Simone Berger, CHRO of STADA Time flies! 2.5 months ago, I packed my suitcase and boarded a plane to Lisbon. By Laura Kirchkamp, Business Manager at STADA I feel so grateful and privileged to be part of the IMD – STADA Grow Higher program. By Stefan Dinev, General Manager STADA Bulgaria at STADA Peter Goldschmidt on LinkedIn CEO of STADA June 13, 2023 My winning formula? A unique growth mindset as key strategic pillar to outgrow the industry! Thanks, John Weeks from IMD for the interview during which I had the opportunity to reflect and share my views on STADA Group successful growth journey. Since I joined as CEO in 2018, I have made it a strategic priority to build a unique growth culture which drives our performance above the industry and makes STADA a holistic broad Healthcare leader covering Consumer Medicines, Generics, and Specialty Pharma. In the interview, I talk about our cultural transformation and how we are building the best team in the industry, sharing one purpose of “Caring for People’s Health as a Trusted Partner” and the common four values of Agility, Entrepreneurship, Integrity, and "OneSTADA": https://lnkd.in/e4ftiAEF Enjoy and looking for your comments and ideas. #Culture #Pharma #Leadership #OneSTADAForGrowth View on LinkedIn Simone Berger on LinkedIn Head of Global Human Resources May 5th, 2023 A special bond between a unique group of great leaders! We finished the STADA Group Top Leadership Program this week with a festive graduation, followed by our Alumni event, where leaders from the past three cohorts came together from around the world. I was impressed to see the connection, trust and friendship that has developed among all of them over the past years! Incredible OneSTADA spirit! Special thanks to my STADA Executive Committee colleagues Miguel Pagan , Christoph Dr. Dengler , Stephan Eder and Boris Doebler for taking the time and enriching the conversations! And also a big thank you to Professors John Weeks and Frédéric Dalsace from IMD for making our Top Leadership Program not just another corporate training but such a special and truly impactful experience for all participants! #growthmindset View on LinkedIn Laura Kirchkamp on LinkedIn Business Manager at STADA May 8, 2023 Time flies! 2.5 months ago, I packed my suitcase and boarded a plane to Lisbon. I was super excited to continue my journey within the STADA Accelerate program and spend six months in our Portuguese affiliate. Little did I know that that I would absolutely fall in love with this country and its kind people (and the food, the weather, the landscape, the list is long…). I could not have hoped for a better start in the team, which has welcomed me so warmly from day one. Lisbon has surely become a home away from home! A special thank you belongs to Ana Ferreira and Ana Reis for supporting me every day and giving me the opportunity to learn and grow in distinct areas. Thank you also to STADA Group and everyone who supported in making this unique opportunity a reality, it is an experience and time I will remember and benefit from my whole life. I am so looking forward to everything waiting for me in the next few months, obrigada! And yes, team meetings come with these amazing sea views :) #OneSTADA #STADAxlrt #growthjourney View on LinkedIn Stefan Dinev on LinkedIn General Manager STADA Bulgaria at STADA Group May 11, 2023 I feel so grateful and privileged to be part of the IMD – STADA Grow Higher program. It’s been an exciting learning journey and I made a commitment to keep sharing the knowledge I have gained with my team. It is energizing and rewarding to be part of an organization where every team member is eager to share, learn and grow! Thank you, Simone Berger and Christos Gallis , for letting me experience this program while meeting strong STADA Group / IMD professionals, making friendships and having enjoying the learning process! #leadershipdevelopment #growth #growhigher #onestada #stadabulgaria View on LinkedIn Consumer Healthcare products STADA is the fourth-largest consumer healthcare company in Europe and markets products internationally in all relevant healthcare categories. The most significant drivers are the Local Hero Brands, strong regional brands and newly acquired products that successfully complement the existing product range. View our brands Improving access to life-changing treatments for patients worldwide Specialty Pharmaceuticals are medicines, that give patients access to innovative treatment options, especially for chronic, severe or rare diseases. STADA’s Specialty portfolio includes innovative treatments for conditions such as Parkinson’s disease and a rare kidney disease, as well as a range of biologic medicines across uses in cancer, eyecare and autoimmune conditions. Through partnerships, we are establishing a sustainable specialty pipeline to deliver on our purpose of “Caring for People’s Health as a Trusted Partner”. Specialty Pharmaceuticals Affordable generics have been the backbone of STADA since 1895 As a major player in the generics sector, we support patient care with affordable medicines. This is especially true in Europe, where STADA ranks as the fourth-largest manufacturer and supplier of generics in terms of sales. Seven out of ten medicines prescribed in Europe are generic, but these account for only about 30% of all pharmaceutical expenditure. Generics Our purpose is ‘Caring for People’s Health as a Trusted Partner’ At STADA, this purpose unites all employees globally as a One STADA team with the aim of bringing health to society. It guides STADA's people in their day-to-day business – and drives the company’s ambition to be the partner of choice in Consumer Healthcare, Generics and Specialty. Our purpose Products Nizoral® Nizoral® Nizoral® is a medical treatment against dandruff. Nizoral® Grippostad® Grippostad® Grippostad® C is a medicine against flu infections and colds. Grippostad® Lunestil® Lunestil® Lunestil® duo-capsule technology offer innovative ways to get a good night’s sleep. Lunestil® Immunology Nephrology Neurology Company About us Products Investors Media Career STADA Worldwide Get in Touch Contact info@stada.de +49 6101 603-0 Compliance Reporting Portal ⧉ FOLLOW US Conditions of Use Privacy Policy Imprint Cookie settings Progenerika © Copyright STADA Arzneimittel AG 2023